Quest PharmaTech Valuation

QPTFF Stock  USD 0.01  0.00  0.00%   
Quest PharmaTech seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Quest PharmaTech from analyzing the company fundamentals such as Shares Outstanding of 169.13 M, price to book of 0.19 X, and Return On Equity of -0.62 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.01
Please note that Quest PharmaTech's price fluctuation is very steady at this time. Calculation of the real value of Quest PharmaTech is based on 3 months time horizon. Increasing Quest PharmaTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Quest pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Quest PharmaTech. Since Quest PharmaTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Quest Pink Sheet. However, Quest PharmaTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0133 Real  0.0112 Hype  0.0133 Naive  0.0133
The real value of Quest Pink Sheet, also known as its intrinsic value, is the underlying worth of Quest PharmaTech Company, which is reflected in its stock price. It is based on Quest PharmaTech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Quest PharmaTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.01
Real Value
0.01
Upside
Estimating the potential upside or downside of Quest PharmaTech helps investors to forecast how Quest pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Quest PharmaTech more accurately as focusing exclusively on Quest PharmaTech's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Naive
Forecast
LowNext ValueHigh
0.010.010.01
Details

Quest PharmaTech Total Value Analysis

Quest PharmaTech is at this time forecasted to have takeover price of 7.81 M with market capitalization of 12.89 M, debt of 1000 K, and cash on hands of 518.76 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Quest PharmaTech fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
7.81 M
12.89 M
1000 K
518.76 K

Quest PharmaTech Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Quest implies not a very effective usage of assets in December.

Quest PharmaTech Ownership Allocation

Quest PharmaTech owns a total of 169.13 Million outstanding shares. Quest PharmaTech holds 16.8 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Quest PharmaTech Profitability Analysis

Net Loss for the year was (85.04 M) with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Quest PharmaTech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Quest PharmaTech and how it compares across the competition.

About Quest PharmaTech Valuation

The pink sheet valuation mechanism determines Quest PharmaTech's current worth on a weekly basis. Our valuation model uses a comparative analysis of Quest PharmaTech. We calculate exposure to Quest PharmaTech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Quest PharmaTech's related companies.
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications skin penetrating active molecules for cosmetic and pharmaceutical use and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest Pharmatech is traded on OTC Exchange in the United States.

8 Steps to conduct Quest PharmaTech's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Quest PharmaTech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Quest PharmaTech's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Quest PharmaTech's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Quest PharmaTech's revenue streams: Identify Quest PharmaTech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Quest PharmaTech's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Quest PharmaTech's growth potential: Evaluate Quest PharmaTech's management, business model, and growth potential.
  • Determine Quest PharmaTech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Quest PharmaTech's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Quest PharmaTech Growth Indicators

Investing in growth stocks can be very risky. If the company such as Quest PharmaTech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding168.2 M
Quarterly Earnings Growth Y O Y-0.86
Retained Earnings48.8 M

Complementary Tools for Quest Pink Sheet analysis

When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities